-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-safety_research.pdf
July 01, 2009 - DRN: Report 1
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of
AHRQ’s Effective Health Care program. It is a collaborative network of research centers that
support the rapid development of new scientific information and analytic tools. The DEcIDE
network assists heal…
-
effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
January 01, 2012 - AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 08: Functional Limitations and Disability
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
www.ahrq.gov
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antibiotics-respiratory-infection_disposition-comments.pdf
January 27, 2016 - Disposition of Comments for CER 163 Appropriate Antibiotics
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Improving Antibiotic Prescribing for Uncomplicated Acute
Respiratory Tract Infections
Draft review available for public comment from February 10, 2015 to Ma…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
October 25, 2010 - Future Research Needs Document
Future Research Needs To Reduce the Risk of Primary Breast Cancer in Women was available
for public comment from September 29, 2010, to October 25, 2010. In response to questions and
suggestions received, revisions were made in this version to clarify that no incentives were
offere…
-
effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_executive.pdf
March 01, 2011 - Executive Summary CER 171: Noninvasive Testing for Coronary Artery Disease
1
Comparative Effectiveness Review
Number 171
Noninvasive Testing for Coronary
Artery Disease
Executive Summary
Background
Nature and Burden of Coronary
Artery Disease
The public health and economic
burdens of coronary artery dise…
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-9_tables.xlsx
January 01, 2009 - 1. Antidiab
Prevalence of Drugs by Antidiabetic Class, Among Medicare Parts A, B, and D FFS Population With Diabetes, by Age, Gender, and Race, 2006-2009
Age is calculated as of December 31 of the year.
Note: A dash signifies small cell count (<11).
Breakdown Category Year Alpha Glucosidase Inhibitors Amylin A…